Publikationen von Hemmelmann, Claudia

Beelen, Dietrich Wilhelm , Trenschel, Rudolf, Stelljes, Matthias, Groth, Christoph, Masszi, Tamás, Reményi, Péter, Wagner-Drouet, Eva-Maria, Hauptrock, Beate, Dreger, Peter, Luft, Thomas, Bethge, Wolfgang, Vogel, Wichard, Ciceri, Fabio, Peccatori, Jacopo, Stölzel, Friedrich, Schetelig, Johannes, Junghanß, Christian, Grosse-Thie, Christina, Michallet, Mauricette, Labussiere-Wallet, Hélène, Schaefer-Eckart, Kerstin, Dressler, Sabine, Grigoleit, Goetz Ulrich, Mielke, Stephan , Scheid, Christof, Holtick, Udo, Patriarca, Francesca, Medeot, Marta, Rambaldi, Alessandro, Micò, Maria Caterina, Niederwieser, Dietger, Franke, Georg-Nikolaus, Hilgendorf, Inken , Winkelmann, Nils Rudolf, Russo, Domenico, Socié, Gérard, Peffault de Latour, Régis, Holler, Ernst, Wolff, Daniel, Glass, Bertram, Casper, Jochen, Wulf, Gerald, Menzel, Helge, Basara, Nadezda, Bieniaszewska, Maria, Stuhler, Gernot, Verbeek, Mareike, Grass, Sandra, Iori, Anna Paola, Finke, Juergen, Benedetti, Fabio, Pichlmeier, Uwe, Hemmelmann, Claudia, Tribanek, Michael, Klein, Anja, Mylius, Heidrun Anke, Baumgart, Joachim, Dzierzak-Mietla, Monika und Markiewicz, Miroslaw (2020) Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial. The Lancet Haematology 7 (1), e28-e39. Volltext nicht vorhanden.

Kalwak, Krzysztof, Mielcarek, Monika, Patrick, Katharine, Styczynski, Jan , Bader, Peter, Corbacioglu, Selim, Burkhardt, Birgit, Sykora, Karl Walter, Drabko, Katarzyna , Gozdzik, Jolanta, Fagioli, Franca, Greil, Johann, Gruhn, Bernd, Beier, Rita, Locatelli, Franco, Müller, Ingo, Schlegel, Paul Gerhardt, Sedlacek, Petr, Stachel, Klaus Daniel, Hemmelmann, Claudia, Möller, Ann-Kristin, Baumgart, Joachim und Vora, Ajay (2020) Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies. Bone Marrow Transplantation 55 (10), S. 1996-2007. Volltext nicht vorhanden.